Matches 101 - 150 out of 409 < 1 2 3 4 5 6 7 8 9 >
Match Document Document Title
6849620 N-(azabicyclo moieties)-substituted hetero-bicyclic aromatic compounds for the treatment of disease  
The invention provides compounds of Formula I: wherein Azabicyclo is W 0 is a bicyclic moiety and is These compounds may be in the form of pharmaceutical salts or...
6841563 Aryloxy propanolamines for improving livestock production  
Disclosed is a compound represented by structural formula (I): R1 is a substituted or unsubstituted aryl group. R2 and R3 are independently —H, a C1-C4 straight chained or branched alkyl group....
6835743 Pesticidal pyrazoles and derivatives  
Process for the protection of a building that has already been built or is going to be built, whereby an effective amount of an insecticidally active compound is spread around or under the said...
6831075 Heterocyclic substituted pyrazolones  
The present invention is directed to novel heterocyclic substituted pyrazolones, including pharmaceutical compositions, diagnostic kits, assay standards or reagents containing the same, and methods...
6828327 Macroheterocylic compounds useful as kinase inhibitors  
This invention is directed to macroheterocyclic compounds useful as kinase or dual-kinase inhibitors, methods for producing such compounds and methods for treating or ameliorating a kinase or...
6825209 Compounds having unique CB1 receptor binding selectivity and methods for their production and use  
Compounds are provided that are amide analogs of SR141716A having unique CB1 receptor selectivity and providing WIN sparing binding characteristics, pharmaceutical compositions containing the...
6822001 Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents  
Combination therapies are provided for the treatment of proliferative disorders which use a pentafluorobenzenesulfonamide of formula I and an antineoplastic agent such as gemcitabine or paclitaxel.
6797712 Substituted amino-furan-2-yl-acetic acid and amino-thien-2-yl-acetic acid derivatives and their use in the treatment of migraine and pain  
Compounds of formula I, or a pharmaceutically acceptable salt thereof, The compounds of the present invention are suitable for the treatment of pain and migraine. Also disclosed are method for...
6770664 Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods  
Bicyclic heterocyclic substituted phenyl oxazolidinone compounds of the formula: wherein Y is a radical of Formulae II or III: in which the substituents have the meaning indicated in the...
6759428 Indole nitriles  
Compounds of the formula (I) wherein m, n, R 1 , R 2 , R 3 , R 4 , R 5 and R 6 are as described herein, together with methods for making the compounds and using the compounds for treatment of...
6743817 Substituted fused pyrroleimines and pyrazoleimines  
Disclosed are compounds of the formula and the pharmaceutically acceptable salts thereof wherein R, Ar, A, n, R 1 and R 2 are defined herein. These compounds are highly selective agonists,...
6740654 Squaric acid derivatives  
Squaric acid derivatives of formula (1) are described: wherein Het is an optionally substituted bicyclic fused ring heteroaromatic group; L 2 is a covalent bond or an atom or group —O—,...
6740647 Thrombin inhibitors  
Novel five-membered heterocyclic amidines, their preparation and use as competitive inhibitors of trypsin-like serine proteases, especially thrombin and kininogenases such as kallikrein....
6730312 Pesticidal composition for seed treatment  
The present invention provides an at least quaternary composition for controlling insects or representatives of the order Acarina and microorganisms, which composition comprises: (A) an...
6726937 Antifungal composition  
The present invention provides use of a composition containing 2-n-octyl-4-isothiazolin-3-one and N-n-butyl-1,2-benzisothiazolin-3-one for providing antifungal efficacy to a wood preservative...
6716843 Alpha-amino acid sulphonyl compounds  
Compound of formula (I): wherein: represents an optionally substituted, 5-membered, nitrogen-containing heterocycle, R 1 represents hydrogen, alkyl, acyl, prolyl, alanyl, histidylprolyl or...
6716837 Heterocyclic compounds for the treatment of migraine  
Described herein are compounds useful in the treatment of migraine, which have the general formula: wherein: W is a CH group or a N atom; Z is N or C—R4; B and D are selected independently...
6706745 Biphenylamidine derivatives  
The present invention relates to a biphenylamidine derivative of the general formula (1): or a pharmaceutically acceptable salt thereof, which is a novel compound functioning as a clinically...
6689770 Aryl sulfonyls as factor Xa inhibitors  
The present application describes aryl sulfonyls of formula I: or pharmaceutically acceptable salt or prodrug forms thereof, wherein D, E, and M are defined below, are effective factor Xa...
6649645 Combination therapy of radiation and a COX-2 inhibitor for treatment of neoplasia  
The present invention provides methods to treat or prevent neoplasia disorders in a mammal using a combination of radiation therapy and a cyclooxygenase-2 inhibitor.
6630487 Treatment of insulin resistance with growth hormone secretagogues  
This invention is directed to methods of treating insulin resistance in a mammal which comprise administering an effective amount of a compound of formula I, where the variables are defined in...
6589973 Preparation of selective cyclooxygenase II inhibitors  
A clear, stable novel pharmaceutical preparation of selective cyclooxygenase II inhibitors (COX 2) inhibitors in the parenteral form for the treatment of pain & inflammatory conditions arising...
6589751 Immonological detection of the homocystamide adduct and a thiolactone immunoassay for endogeneous homocysteine  
An antibody specific for homocystamide adducts is disclosed. In a preferred embodiment of the present invention, the antibody is used to evaluate the level of homocysteine in a biological sample.
6552062 Indazole derivatives with 5-HT2 receptor activity  
A chemical compound of formula (I) wherein R 1 to R 3 are independently selected from hydrogen and alkyl; R 4 to R 7 are independently selected from hydrogen, halogen, hydroxy, alkyl, aryl,...
6552051 Energetic nitramine-linked azoles and related compounds as oxidizers, initiators and gas generators  
Novel compounds are provided having the structural formula R[—N(NO 2 )—L—R 1 ] n wherein R, L, R 1 and n are defined herein. The compounds are useful in a variety of contexts, but are...
6545037 Benzenesulfonamide compounds  
A compound of formula (I): which is useful as a TXA 2 and 5-HT 2 receptor and pharmaceutical compositions containing the same.
6534534 Pharmaceutical composition active in reducing production of MCP-1 protein  
The present application relates to a method of treating atherosclerosis by administering to a patient a compound of formula: and/or salts thereof with pharmaceutically acceptable organic or...
6534504 Indazolyloxy propanolamines for improving livestock production  
Disclosed is compound represented by Structural Formula (I), wherein Ring A, Ring B and Ring C are independently substituted or unsubstituted. R1 and R2 are independently a C1-C4 straight chained...
6521656 Remedies for male sterility  
Efficacious remedies for male sterility which are in the form of preparations containing as the active ingredient an adenosine A 1 antagonist.
6518294 Fused pyrazolyl compounds  
A fused pyrazolyl compound of the following formula: wherein each of Ar 1 , Ar 2 , and Ar 3 , independently, is phenyl, thienyl, pyrrolyl, or furyl, optionally substituted with halo, alkyl,...
6518266 1- Aryl-3-thioalkyl pyrazoles, the synthesis thereof and the use thereof as insecticides  
The present invention is directed to novel pyrazole derivatives and their use as pesticidal agents. The pyrazole derivatives have Formula I: or a salt thereof, where R 1 represents R 5 O, R 5...
6509367 Pyrazole cannabinoid agonist and antagonists  
Disclosed are pyrazole derivatives of formula I: Where R 1 , R 2 , R 3 , and R 4 are defined as in the specification described. These compounds are antagonists of the brain cannabinoid (CB-1)...
6486203 Treating inflammatory diseases of the head and neck with cyclooxygenase-2 inhibitors  
A patient with an inflammatory disease of the head and neck is treated with a therapeutic amount of a selective inhibitor of cyclooxygenase-2 or a cyclooxygenase-2 inhibitor from a natural source....
6476060 4,5-dihydro-1H-pyrazole derivatives having CB1-antagonistic activity  
The present invention relates, among many things, to novel 4,5-dihydro-1H-pyrazole compounds which can be potent antagonists of the cannabis CB 1 -receptor. The compounds have the formula (I) ...
6472416 Sulfonylphenylpyrazole compounds useful as COX-2 inhibitors  
The present invention encompasses novel sulfonylphenylpyrazole compounds useful in the treatment of cyclooxygenase-2 mediated diseases.
6469040 Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia  
This invention relates to the use of cyclooxygenase-2 inhibitors or derivatives thereof in preventing and treating neoplasia. In particular, the invention describes the method of preventing and...
6462068 Heterocyclylmethyl-substituted pyrazole derivatives  
The present invention relates to new heterocyclylmethyl-substituted pyrazole derivatives, processes for their preparation and their use as medicaments, in particular as medicaments for treatment of...
6458823 Diaminopyrazoles  
This invention concerns the treatment of smooth muscle spasticity or excess muscle contraction such as urge urinary incontinence with a compound of the formula wherein: R 1 and R 2 are...
6451834 Indeno&lsqb 1,2-c&rsqb -, naphtho&lsqb 1,2-c&rsqb - and benzo&lsqb 6,7&rsqb cyclohepta&lsqb 1,2-c&rsqb pyrazole derivatives  
Chemical compounds that are derivatives of indeno[1,2-c]-, naphtho[1,2-c]- and benzo[6,7]cyclohepta[1,2-c]pyrazole are inhibitors of tyrosine kinase activity. Several of the tyrosine kinases, whose...
6448242 Cyclic amide compounds  
The invention relates to compounds represented by the following general formula (1): wherein A is an aromatic compound which may be substituted, or the like, B is a nitrogen atom or CH, X is a...
6436978 Guanidinylamino heterocycle compounds useful as α-2 adrenoceptor agonists  
This invention involves compounds having the following structure: as described in the Claims; and enantiomers, optical isomers, stereoisomers, diastereomers, tautomers, addition salts,...
6432995 Aromatic heterocyclic compounds and their use as anti-inflammatory agents  
Novel aromatic heterocyclic compounds inhibit cytokines production involved in immunoregulation and inflammation such as interleukin-1 and tumor necrosis factor production. The compounds are...
6426341 Treatment for diabetic complications  
This invention is directed to methods, pharmaceutical compositions and kits comprising an aldose reductase inhibitor (ARI), a prodrug thereof or a pharmaceutically acceptable salt of said ARI or...
6414011 Aryl substituted pyrazoles, and pyrroles, and the use thereof  
This invention relates to compounds having the Formula I: or a pharmaceutically acceptable salt, prodrug or solvate thereof, wherein Het and R 5 -R 13 are set in the specification. The...
6414009 Heterocyclylmethyl-substituted pyrazol derivatives  
The present invention relates to new heterocyclylmethyl-substituted pyrazole derivatives, processes for their preparation and their use as medicaments, in particular as medicaments for treatment of...
6413957 Methods of inhibiting cell proliferation using indeno &lsqb 1,2-c&rsqb pyrazol-4-ones  
The present invention relates to the synthesis of a new class of indeno[1,2-c]pyrazol-4-ones of formula (I): that are potent inhibitors of the class of enzymes known as cyclin dependent kinases,...
6407103 Indeno &lsqb 1,2-c&rsqb pyrazol-4-ones and their uses  
The present invention relates to the synthesis of a new class of indeno[1,2-c]pyrazol-4-ones of formula (I): that are potent inhibitors of the class of enzymes known as cyclin dependent kinases,...
6403630 Treating cancers associated with overexpression of HER-2/neu  
Cancers associated with overexpression of HER-2/neu are treated with a selective inhibitor of cyclooxygenase-2 as the sole treating agent or said inhibitor in combination regimen with HERCEPTIN®...
6399612 Heteroaryl butyric acids and their derivatives as inhibitors of matrix metalloproteinases  
Heteroaryl butyric acid compounds and derivatives are described as well as methods for the preparation and pharmaceutical compositions of same, which are useful as inhibitors of matrix...
RE37729 4-Heteroaryl-1-piperidinealkylamines and derivatives thereof and their therapeutic utility  
Heteroarylpiperidines, pyrrolidines, and piperazines are useful as antipsychotic and analgesic agents. The compounds are especially useful for treating psychoses by administering to a mammal a...
Matches 101 - 150 out of 409 < 1 2 3 4 5 6 7 8 9 >